I personally don't believe the possibility of Teva getting approval as a non-substitutable generic is realistic. The FDA would essentially be saying it's not the same drug, but is nevertheless safe and effective, and I just don't see them doing that without requiring trials.
"Fully substitutable" is of course a very big deal in terms of sales.
Market Data 
Markets 
AI
